HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Anti-Cellulite Backlash Reveals Confusion Over Firm’s Offense: Is It The Ad, Or The Product?

Executive Summary

Actress crusader Jameela Jamil led the social media mob against Avon’s anti-cellulite advertising in January, but she herself was called to account by some who themselves felt “shamed” for seeking such products out. The melee that followed provoked questions about the essence of the beauty industry as a whole.

You may also be interested in...



‘Miss The Mark’ With Your Beauty Ad? Don’t Worry, There’s Another Outrage Around The Corner

Beauty Strategy Group’s top execs discuss today’s hypersensitive climate, the ephemerality of outrage online, and the importance of separating social media controversy from consumer and business realities.  

CVS’ ‘Authentic Beauty’ Gets People Talking, Which Isn’t Always A Good Thing

The public response to CVS’ Beauty Mark program, which promotes advertising images that are not digitally altered and requires disclosures on those that are, has been highly favorable overall. But if you give the social media rabble an inch, they’re going to want a mile.

CVS’ ‘Authentic Beauty’ Gets People Talking, Which Isn’t Always A Good Thing

The public response to CVS’ Beauty Mark program, which promotes advertising images that are not digitally altered and requires disclosures on those that are, has been highly favorable overall. But if you give the social media rabble an inch, they’re going to want a mile.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS148488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel